Older age, longer diabetes duration, male sex, and use of insulin, sulfonylurea, calcium channel blockers, aspirin, ticlopidine, clopidogrel and dipyridamole were significantly associated with a higher risk, but dyslipidemia and use of metformin and statin were associated with a significantly lower risk. Here, INS is linked to metabolic syndrome.